Inhaled insulin shows value in artificial pancreas study

Last September, results from a JDRF-funded study were announced by Sansum Diabetes Research Institute and JDRF. This study addresses one of the key limitations of early artificial pancreas systems – the challenge of mealtime dosing of insulin. This is because insulin delivered through the skin by a pump or injections works much slower than insulin […]

Accelerating development progress of artificial pancreas systems

Last September, Medtronic announced FDA approval of its MiniMed 530G with Enlite system (sold outside the United States as the Veo since 2009). JDRF applauded the U.S. Food and Drug Administration (FDA) for its commitment to ensuring patients in the United States can access insulin pumps that can temporarily stop insulin delivery once sensor glucose […]

The Artificial Pancreas Does Its Homework

JDRF-funded researchers across the globe are currently testing artificial pancreas systems. Some clinical trials are inpatient, in which participants stay overnight or for a few days in a hospital or research clinic, while others take place in an outpatient setting. In both cases, a medical team carefully monitors the daily life of each trial volunteer […]

Meet the Researcher

Stephen D. Miller, Ph.D., is the Judy Gugenheim Research Professor of Microbiology–Immunology at Northwestern University Feinberg School of Medicine. Dr. Miller has spent 32 years as a faculty member at Northwestern, where his research focuses on understanding the mechanisms underlying the pathogenesis and immunoregulation of autoimmune diseases, allergic disease, and rejection of tissue and organ […]

JDRF @ ADA 73rd Scientific Sessions: Monday Summary

Welcome to our final daily summary of type 1 diabetes (T1D) research highlights from the ADA’s 73rd Scientific Sessions! Each night, we have been posting summaries of notable sessions and presentations. Below are two relevant sessions from Monday, June 24: From Mice to Men and Back in Diabetic Kidney Disease Diabetic kidney disease remains one of […]

Top Research Highlights

Every day, JDRF leverages the expertise and innovation of distinguished researchers from across the globe to support research for life-changing treatments and ultimately a cure for type 1 diabetes (T1D). Our aim is to progressively reduce the burden of the disease on people’s lives until we can achieve a world without T1D. Please enjoy reading […]

JDRF @ ADA 73rd Scientific Sessions: Sunday Summary

Welcome to our daily summary of  type 1 diabetes (T1D) research highlights from the ADA’s 73rd Scientific Sessions! Each night, we will be posting summaries of notable sessions and presentations.  Below are two relevant sessions from Sunday, June 23: Novel Disease Markers in Type 1 Diabetes For the past several years, JDRF has placed an increasing priority […]

JDRF @ ADA 73rd Scientific Sessions: Saturday Summary

Welcome to our daily summary of type 1 diabetes (T1D) research highlights from the ADA’s 73rd Scientific Sessions!  Each night, we will be posting summaries of notable sessions and presentations.  Below are four relevant sessions from Saturday, June 22: Clinical Trials of T-Cell Therapeutics for Reversing Type 1 Diabetes JDRF continues to place a high priority on […]

JDRF @ ADA 73rd Scientific Sessions: Friday Summary

Welcome to our daily summary of type 1 diabetes (T1D) research highlights from the ADA’s 73rd Scientific Sessions!  Each night, we will be posting summaries of notable sessions and presentations.  Below are two relevant sessions from Friday, June 21.  Beta Cell Failure in Type 1 Diabetes – Cause or Consequences? The fact that T1D is a complicated […]